1,12-Dodecanediol, 2,11-dimethyl-2,11-dipropyl-

Suppliers

Names

[ CAS No. ]:
85018-69-5

[ Name ]:
1,12-Dodecanediol, 2,11-dimethyl-2,11-dipropyl-

[Synonym ]:
2,11-Dimethyl-2,11-dipropyl-1,12-dodecanediol
1,12-Dodecanediol,2,11-dimethyl-2,11-dipropyl

Chemical & Physical Properties

[ Density]:
0.889g/cm3

[ Boiling Point ]:
414.7ºC at 760 mmHg

[ Molecular Formula ]:
C20H42O2

[ Molecular Weight ]:
314.54600

[ Flash Point ]:
172.2ºC

[ Exact Mass ]:
314.31800

[ PSA ]:
40.46000

[ LogP ]:
5.70460

[ Index of Refraction ]:
1.464

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
JR2435710
CHEMICAL NAME :
1,12-Dodecanediol, 2,11-dimethyl-2,11-dipropyl-
CAS REGISTRY NUMBER :
85018-69-5
LAST UPDATED :
199603
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C20-H42-O2
MOLECULAR WEIGHT :
314.62

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
EPXXDW European Patent Application. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Volume(issue)/page/year: #0064286
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
EPXXDW European Patent Application. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Volume(issue)/page/year: #0064286

Related Compounds

  • 1,12-Dodecanediol, 2,11-diethyl-2,11-dimethyl-
  • [2,11-dimethyl-2-propyl-11-(pyridine-3-carbonyloxymethyl)tetradecyl] p yridine-3-carboxylate
  • Dodecanedioic acid, 2,11-dimethyl-2,11-dipropyl-
  • 2,11-dibutyl-2,11-dimethyl-dodecane-1,12-diol
  • 4,4,5,5,6,6,7,7,8,8,9,9-dodecafluoro-2,11-diiodododecane-1,12-diol
  • 1,12-dibromododecane-2,11-dione
  • Perfluoro-2,2,9,9-tetramethyldeca-3,7-diene
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • Methyl 5-bromo-2,3-dioxo-1H-indole-7-carboxylate
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(2-Methoxyphenyl)-4-[3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-1,4-diazepane-1-carboxamide
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde